Australia tightened cosmetic clinic advertising rules substantially on 2 September 2025, and the clinics still leaning on before/after carousels, patient testimonials and appearance-prediction filters are the ones now getting ads rejected or pulled entirely. The clinics that win instead build a compliant funnel around practitioner credibility, process transparency and genuine education — then track it properly, because a cheap lead that never books a consultation isn't actually cheap.
Australia's higher treatment values make the economics work even with AHPRA's restrictions in place. Meta cost-per-click across Australian industries averages around A$1.47, with CPM typically A$9.63–21.73 depending on category — general cross-industry figures, not aesthetic-specific, since we don't yet have a large enough managed AU aesthetic-clinic sample to publish a dedicated CPL band (see our ad benchmarks page for the sourced figures and why the vertical-specific band stays unpublished rather than guessed).
What's different about advertising this in Australia
Cosmetic procedure advertising in Australia sits under the AHPRA (Australian Health Practitioner Regulation Agency) cosmetic procedure advertising guidelines — which took effect 2 September 2025 — plus separate TGA (Therapeutic Goods Administration) restrictions on advertising prescription-only medicines. The September 2025 update strengthened an already-strict testimonial ban to explicitly cover influencer and re-shared patient content, banned apps or tools that predict a person's post-procedure appearance, prohibited advertising to under-18s outright, and introduced a mandatory 7-day cooling-off period for under-18 patients between consultation and any procedure. Requirements are described here in practical terms — always confirm specifics against AHPRA's own published guidance or your adviser.
The three imports from unregulated-market campaigns that fail fastest in Australia: before/after imagery (prohibited outright, no consent-based exception), patient or influencer testimonials (banned regardless of who posts them), and named prescription-medicine mentions (Botox, dermal fillers and similar can't be named in public advertising under TGA rules — refer to the treatment category generically instead). Since 1 July 2023 the title "surgeon" is also legally protected — only specialist-registered surgeons may use it, including "cosmetic surgeon." None of this means compliant advertising can't convert — it means the conversion has to come from education, credentials and a genuine consultation pathway instead. Self-check your own ad copy against these exact rules with our free AHPRA & TGA Ad Compliance Checker.